Guangxi Liuzhou Pharm Co Ltd (603368) — Capital Reinvestment Ratio
Guangxi Liuzhou Pharm Co Ltd (603368) has a Capital Reinvestment Ratio of 0.81x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.64 Million) in capital expenditures (CN¥36.80 Million). Check 603368 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangxi Liuzhou Pharm Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Guangxi Liuzhou Pharm Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 603368 cash generation efficiency.
Annual Capital Reinvestment Ratio for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. See Guangxi Liuzhou Pharm Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥838.51 Million | CN¥147.87 Million | ▼ -39.4% |
| 2023 | 0.29x | CN¥594.41 Million | CN¥172.94 Million | ▼ -19.6% |
| 2022 | 0.36x | CN¥506.43 Million | CN¥183.28 Million | ▼ -54.4% |
| 2021 | 0.79x | CN¥332.88 Million | CN¥264.04 Million | ▲ +101.4% |
| 2020 | 0.39x | CN¥664.69 Million | CN¥261.81 Million | ▼ -34.8% |
| 2019 | 0.60x | CN¥412.91 Million | CN¥249.54 Million | ▼ -95.0% |
| 2018 | 12.18x | CN¥22.30 Million | CN¥271.61 Million | ▲ +936.7% |
| 2016 | 1.17x | CN¥108.39 Million | CN¥127.33 Million | ▼ -64.7% |
| 2013 | 3.33x | CN¥22.33 Million | CN¥74.31 Million | ▲ +1472.1% |
| 2012 | 0.21x | CN¥60.51 Million | CN¥12.81 Million | ▼ -23.2% |
| 2011 | 0.28x | CN¥133.38 Million | CN¥36.78 Million | — |